✦ LIBER ✦

Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer

✍ Scribed by Jin S. Lee; Herman I. Libshitz; Frank V. Fossella; William K. Murphy; Arlita C. Pang; Scott M. Lippman; Dong M. Shin; Isaiah W. Dimery; Bonnie S. Glisson; Waun K. Hong

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 576 KB
Volume: 68
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19910901)68:5<959::aid-cncr2820680508>3.0.co;2-v

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Esophageal complications from combined c

Esophageal complications from combined chemoradiotherapy (cyclophosphamide + adriamycin + cisplatin + xrt) in the treatment of non-small cell lung cancer

✍ Theera Umsawasdi; Manuel Valdivieso; H.Thomas Barkley Jr.; Daniel J. Booser; Del 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 1023 KB

5-fluorouracil, etoposide, and cisplatin

5-fluorouracil, etoposide, and cisplatin in the management of metastatic non-small cell lung cancer

✍ Lawrence Flaherty; Antoinette Wozniak; Bruce Redman; Michael Kraut; Silvana Mart 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 2 views

Vindesine and high-dose cisplatin in the

Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer

✍ Fuks, Joachim Z. ;Patel, Halesh ;van Echo, David A. ;Hornedo, Javier ;Aisner, Jo 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB

Cisplatin and novobiocin in the treatmen

Cisplatin and novobiocin in the treatment of non-small cell lung cancer. A southwest oncology group study

✍ Georgiana K. Ellis; Robert B. Livingston; John Crowley; John W. Goodwin; Laura H 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 2 views

Combination chemotherapy with mitomycin-

Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer

✍ Niell, Harvey B. ;Griffin, John P. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

The drug combination of mitomycin-C, cisplatin, and vinblastine was administered to 30 patients with stage III non-small-cell lung cancer. All patients had a performance status of 50% or greater, had evaluable disease, and had not received previous chemotherapy. The overall response rate was 37% wit

Mitomycin C, vinblastine and cisplatin c

Mitomycin C, vinblastine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer

✍ Fumio Nomura; Kaoru Shimokata; Hiroshi Saito; Shuzo Sakai; Atsushi Watanabe; Hid 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 277 KB